Accro Bioscience (Suzhou) Limited
4 clinical trials · Sponsor
◉ Watch Accro Bioscience (Suzhou) Limited
| Record | Firm | Date |
|---|---|---|
| A Study of AC-101 Tablets in Patients With Ulcerative Colitis (NCT07755241) | Accro Bioscience (Suzhou) Limited | 2026-08-28 |
| A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis (NCT07083193) | Accro Bioscience (Suzhou) Limited | 2025-01-20 |
| A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD. (NCT07070674) | Accro Bioscience (Suzhou) Limited | 2024-07-25 |
| A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis (NCT06972888) | Accro Bioscience (Suzhou) Limited | 2024-04-23 |
Track Accro Bioscience (Suzhou) Limited automatically
Every clearance here is in the API, with alerts when new ones post.